These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 18563216)

  • 1. [Susceptibility to antimicrobial agents of rapidly growing mycobacteria].
    Ruiz-Aragón J; García-Agudo L; Flores S; Rodríguez MJ; Marín P; García-Martos P
    Rev Esp Quimioter; 2007 Dec; 20(4):429-32. PubMed ID: 18563216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates.
    Hoel T; Casals JB; Eng J
    APMIS; 1993 Jan; 101(1):27-32. PubMed ID: 8457323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis.
    Reddy AK; Garg P; Babu KH; Gopinathan U; Sharma S
    Curr Eye Res; 2010 Mar; 35(3):225-9. PubMed ID: 20373881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapidly growing mycobacteria in King Chulalongkorn Memorial Hospital and review of the literature in Thailand.
    Phowthongkum P; Prasanthai V; Udomsantisook N; Suankratay C
    J Med Assoc Thai; 2005 Aug; 88(8):1153-62. PubMed ID: 16404850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
    Gui J; Wang F; Hong CY; Li JL; Liang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria.
    Shen GH; Wu BD; Hu ST; Lin CF; Wu KM; Chen JH
    Int J Antimicrob Agents; 2010 Apr; 35(4):400-4. PubMed ID: 20138481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
    Woods GL; Bergmann JS; Witebsky FG; Fahle GA; Wanger A; Boulet B; Plaunt M; Brown BA; Wallace RJ
    J Clin Microbiol; 1999 Jun; 37(6):1676-82. PubMed ID: 10325306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro sensitivity of Mycobacterium chelonae strains to various antimicrobial agents].
    Hernández García AM; Arias A; Felipe A; Alvarez R; Sierra A
    Microbiologia; 1995 Dec; 11(4):485-90. PubMed ID: 8588844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapidly growing mycobacterial infections: spectrum of diseases, antimicrobial susceptibility, pathology and treatment outcomes.
    Sungkanuparph S; Sathapatayavongs B; Pracharktam R
    J Med Assoc Thai; 2003 Aug; 86(8):772-80. PubMed ID: 12948277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for sterilizing activity of antibiotic combinations in an acid model of rapidly growing mycobacteria during the stationary phase of growth.
    Cremades R; Santos A; Rodríguez JC; García-Pachón E; Ruiz M; Escribano I; Royo G
    Chemotherapy; 2009; 55(2):114-8. PubMed ID: 19155619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel.
    Cavusoglu C; Gurpinar T; Ecemis T
    New Microbiol; 2012 Jan; 35(1):73-6. PubMed ID: 22378556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
    Özkarataş MH; Arslan N; Esen N; Özkütük AA
    Mikrobiyol Bul; 2023 Apr; 57(2):220-237. PubMed ID: 37067207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of in vitro susceptibility to antimicrobials of rapidly growing mycobacteria by E-test].
    García-Agudo L; García-Martos P; Jesús I; Rodríguez-Iglesias M
    Rev Med Chil; 2009 Jul; 137(7):912-7. PubMed ID: 19802419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility.
    Uslan DZ; Kowalski TJ; Wengenack NL; Virk A; Wilson JW
    Arch Dermatol; 2006 Oct; 142(10):1287-92. PubMed ID: 17043183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan.
    Yang SC; Hsueh PR; Lai HC; Teng LJ; Huang LM; Chen JM; Wang SK; Shie DC; Ho SW; Luh KT
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1958-62. PubMed ID: 12760874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of rapidly growing Mycobacteria isolates in a general hospital: reports from the hospital microbiology laboratory].
    Tazawa S; Marumo K; Nakamura Y; Narushima M; Higuchi D
    Kekkaku; 2001 May; 76(5):419-26. PubMed ID: 11449697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro efficacy of imipenem in combination with six antimicrobial agents against Mycobacterium abscessus.
    Miyasaka T; Kunishima H; Komatsu M; Tamai K; Mitsutake K; Kanemitsu K; Ohisa Y; Yanagisawa H; Kaku M
    Int J Antimicrob Agents; 2007 Sep; 30(3):255-8. PubMed ID: 17616451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility testing of rapidly growing mycobacteria by microdilution - experience of a tertiary care centre.
    Set R; Rokade S; Agrawal S; Shastri J
    Indian J Med Microbiol; 2010; 28(1):48-50. PubMed ID: 20061764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of linezolid against rapidly growing mycobacteria.
    Wallace RJ; Brown-Elliott BA; Ward SC; Crist CJ; Mann LB; Wilson RW
    Antimicrob Agents Chemother; 2001 Mar; 45(3):764-7. PubMed ID: 11181357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multicenter evaluation of a newly developed microdilution test, brothMIC NTM to determine minimum inhibitory concentrations of antimicrobial agents for nontuberculous mycobacteria].
    Yamane N; Onaga S; Saitoh H; Toyoshima S; Shimojima M; Kawahara S; Takashima T; Yamashita T
    Rinsho Byori; 2002 Apr; 50(4):381-91. PubMed ID: 12014018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.